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PThere is a tide in the affairs of men.
Which, taken at the flood, leads on to fortune;
Omitted, all the voyage of their life
Is bound in shallows and in miseries.
On such a full sea are we now afloat,
And we must take the current when it serves,
Or lose our ventures.
—William Shakespeare (1)
The well-done paper by Chiribiri et al. (2) in this
issue of iJACC has 2 signal points of interest: one
as it pertains to coronary physiology and the
other as it pertains to the changing face of health
care. Let us be scientists for the moment and
explore the first point first.
See page 600
Cardiac magnetic resonance (CMR) imaging has
high spatial resolution. Consequently, much in the
heart that was beyond scope is now visible. The
present study introduces a semiquantitative myocar-
dial perfusion method to aid in the interpretation of
stress CMR results by taking advantage of the
physiological differences in myocardial blood flow
(MBF) between the endocardium and epicardium
during hyperemic stress and the spatial resolution of
contrast CMR to capture these differences. The
measured flow gradient across the ventricular wall
correlated moderately well with an independent
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Mossaver-Rahmani Center for Business and Government,
Harvard Kennedy School of Government, Harvard University, Cam-c
bridge, Massachusetts. Dr. Christian has reported that he has no
relationships relevant to the contents of this paper to disclose.easure of coronary flow reserve assessed using a
ressure-sensor wire within the coronary artery.
mportantly, the gradient can be displayed graphi-
ally in a user-friendly format, providing some of
he first semiquantitative reader aids for this tech-
ique (along with another recent article in iJACC)
3). The exclusion of patients with congestive heart
ailure, coronary artery bypass grafting, or prior
yocardial infarction are certainly populations
here performance of noninvasive testing is crucial.
hese and the length for processing studies with
his algorithm are areas that need to be addressed in
he future.
The original theory of coronary flow reserve
tates that during pharmacologic hyperemia, MBF
ncreases from 1.0 ml/min/g in tissue to 4.0 to 5.0
l/min/g in territories with normal arteries, and
ess (1.0 to 3.0 ml/min/g) in zones supplied by
bstructed vessels. This concept was largely based
n an early O-15 positron emission tomography
PET) study when transmural resolution was less
iscriminating (4). Perfusion defects generated
rom pharmacological vasodilation were termed
flow reserve abnormalities,” not ischemia, as there
as no mismatch of MBF to oxygen demand.
efect MBF was thought to be above resting levels
ut less than maximal. But there is mounting
vidence that this concept should be revised. The
esults of this CMR study and others (3) suggests
hat MBF in the subendocardium falls below rest-
ng levels in the setting of single-vessel disease
uring hyperemia, whereas MBF in the subepicar-
ium increases, much like the redistribution of
eawater at low tide. This produces the visual
ransmural gradient reported by Chiribiri et al. (2).
uch a scenario is still consistent with the original
ET data that spawned the coronary flow reserve
oncept. For example, if we divide a myocardial
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611segment into endocardial and epicardial zones at
rest and during hyperemia, the following scenario is
possible:
MBFat rest :
endocardial  1.0 ml/min/g
epicardial  1.0 ml/min/g
 transmural MBF  1.0 ml/min/g
BFat hyperemia :
ndocardial  0.7 ml/min/g
picardial  2.5 ml/min/g
 transmural MBF  1.6 ml/min/g
Using a technique that can only assess transmural
ow, such as single-photon emission computed
omography or early PET, would conclude that
BF increased, whereas the regionality of the
rocess is uncovered with higher-resolution imag-
ng. Dipyridamole echo wall motion abnormalities
n single-vessel disease and other fractional flow
eserve studies support the concept of true ischemia
eing produced during hyperemia from a redistri-
ution gradient of flow across the ventricular wall.
efining the mechanism, in the absence of an
ncrease in oxygen demand, opens an intriguing line
f possible research.
Despite its inherent superiority in resolution and
etail, CMR remains outside the mainstream of
maging for coronary artery disease. In contrast to its
azzling cardiac function and viability sequences, the
erfusion sequence is a first-pass affair, low in signal
nd prone to artifact. The technique takes technical
xperience to perform and interpret. These problems
re reminiscent of nuclear imaging in the era of
hallium-201. One approach that worked for nuclear
ardiology, in addition to developing new perfusion
gents, was the establishment of semiquantitative
lgorithms that gave a “second read” to the subjective
nterpretation. These were based on a comparison of
he image counts to a normal sex-specific dataset of
mages, and displayed agreement and discrepancies
raphically. These programs grew in sophistication
nd accuracy, and became standard analysis software
ackages on most nuclear systems. Such aids allowed
or more definitive and standardized reports, and
ider acceptance of the modality within clinical med-
cine. The present study (2) is a significant step toward
ringing CMR into mainstream imaging through this
pproach.
In trying to make CMR more user friendly, one
onders about the fate of high-tech, high-costmaging. The case of another imaging technology—
lasma television—is illustrative. Disruptive inno-
ation in a market is the introduction of a product
hat performs with a mild loss of quality but with a
ajor drop in marginal cost (5). Flat panel liquid
rystal display televisions were such an example, as
uality was almost as good as plasma television, but
t a fraction of the cost. It is hard to find a plasma
creen television these days.
Which brings out the second point: the tide in
ealthcare reimbursement is about to turn. Imaging
ill go from a revenue-generating center to a cost
enter with the introduction of bundled payments
nd accountable care organizations. Consequently,
he system will be looking hard at potential disrup-
ive innovations that can do the job almost as well
ut at considerably lower cost. Plasma screen pro-
ucers beware.
Medicine has been a market failure in the classic
conomic sense, partly due to the highly asymmetric
nformation that has existed between providers and
onsumers (patients) in terms of evaluating medical
ests. By changing to a fixed sum to spend per
atient, the role of the consumer will shift from the
nsured patient to the ordering physician, who has a
take in the final cost. This creates something more
kin to a functioning market where the consumer is
nformed to make choices about the diagnostic
roduct. For coronary artery disease, it seems likely
hat the pressure will be toward use of coronary
ngiography as both a diagnostic and therapeutic
odality for all but the very low-risk patients in
rder to minimize cost uncertainty. Although this
ay not be optimal care, we do not live in optimal
imes. The challenge for imaging is to stay in the
ame by being simpler and cost effective in relation
o coronary angiography. CMR is in the compli-
ated and expensive category. But by taking advan-
age of its superior imaging characteristics and
omprehensive information, a concerted effort by
endors and investigators to make acquisition and
eading more automated, and reducing the cost to
ompetitive levels, it can be that disruptive innova-
or. For on such a full sea are we now afloat, and we
ust take the current when it serves, or lose our
entures.
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